These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8617752)

  • 1. Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors.
    Shen F; Triezenberg SJ; Hensley P; Porter D; Knutson JR
    J Biol Chem; 1996 Mar; 271(9):4827-37. PubMed ID: 8617752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical amino acids in the transcriptional activation domain of the herpesvirus protein VP16 are solvent-exposed in highly mobile protein segments. An intrinsic fluorescence study.
    Shen F; Triezenberg SJ; Hensley P; Porter D; Knutson JR
    J Biol Chem; 1996 Mar; 271(9):4819-26. PubMed ID: 8617751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific interactions with TBP and TFIIB in vitro suggest that 14-3-3 proteins may participate in the regulation of transcription when part of a DNA binding complex.
    Pan S; Sehnke PC; Ferl RJ; Gurley WB
    Plant Cell; 1999 Aug; 11(8):1591-602. PubMed ID: 10449590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered promoter binding of the TATA box-binding factor induced by the transcriptional activation domain of VP16 and suppressed by TFIIA.
    Liljelund P; Ingles CJ; Greenblatt J
    Mol Gen Genet; 1993 Dec; 241(5-6):694-9. PubMed ID: 8264543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease footprinting reveals a surface on transcription factor TFIIB that serves as an interface for activators and coactivators.
    Hori R; Pyo S; Carey M
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6047-51. PubMed ID: 7597078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical mutations reveal TATA-box binding protein surfaces required for activated transcription in vivo.
    Bryant GO; Martel LS; Burley SK; Berk AJ
    Genes Dev; 1996 Oct; 10(19):2491-504. PubMed ID: 8843200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the interaction between the acidic activation domain of VP16 and the RNA polymerase II initiation factor TFIIB.
    Gupta R; Emili A; Pan G; Xiao H; Shales M; Greenblatt J; Ingles CJ
    Nucleic Acids Res; 1996 Jun; 24(12):2324-30. PubMed ID: 8710503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation by TFIIB mutants that are severely impaired in interaction with promoter DNA and acidic activation domains.
    Chou S; Struhl K
    Mol Cell Biol; 1997 Dec; 17(12):6794-802. PubMed ID: 9372910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein.
    Mahanta SK; Scholl T; Yang FC; Strominger JL
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6324-9. PubMed ID: 9177216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with VP16 and TFIIB that mediate transcriptional activation.
    Klemm RD; Goodrich JA; Zhou S; Tjian R
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5788-92. PubMed ID: 7597030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of variable density self-assembled monolayers to probe the structure of a target molecule.
    Bamdad C
    Biophys J; 1998 Oct; 75(4):1989-96. PubMed ID: 9746540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human general transcription factor TFIIB: conformational variability and interaction with VP16 activation domain.
    Hayashi F; Ishima R; Liu D; Tong KI; Kim S; Reinberg D; Bagby S; Ikura M
    Biochemistry; 1998 Jun; 37(22):7941-51. PubMed ID: 9609687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
    Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
    J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drosophila TAF(II)230 and the transcriptional activator VP16 bind competitively to the TATA box-binding domain of the TATA box-binding protein.
    Nishikawa J; Kokubo T; Horikoshi M; Roeder RG; Nakatani Y
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):85-90. PubMed ID: 8990165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical mechanism of transcriptional activation by GAL4-VP16.
    Tantin D; Chi T; Hori R; Pyo S; Carey M
    Methods Enzymol; 1996; 274():133-49. PubMed ID: 8902801
    [No Abstract]   [Full Text] [Related]  

  • 16. Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation.
    Kim TK; Roeder RG
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4170-4. PubMed ID: 8183887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro.
    Huh JR; Park JM; Kim M; Carlson BA; Hatfield DL; Lee BJ
    Biochem Biophys Res Commun; 1999 Mar; 256(1):45-51. PubMed ID: 10066420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB.
    Goodrich JA; Hoey T; Thut CJ; Admon A; Tjian R
    Cell; 1993 Nov; 75(3):519-30. PubMed ID: 8221891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gal4-VP16 and Gal4-AH increase the orientational and axial specificity of TATA box recognition by TATA box binding protein.
    Kays AR; Schepartz A
    Biochemistry; 2002 Mar; 41(9):3147-55. PubMed ID: 11863454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of in vitro interactions implicates TATA-binding protein as a target of the VP16C transcriptional activation region.
    Nedialkov YA; Triezenberg SJ
    Arch Biochem Biophys; 2004 May; 425(1):77-86. PubMed ID: 15081896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.